Anna Börjesson
31 – 40 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
(
- Contribution to journal › Article
-
Mark
Pulmonary Injury Following Intestinal Ischemia and Reperfusion in Rats
2005)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Multimodal management - of value in fulminant acute pancreatitis?
(
- Contribution to journal › Article
-
Mark
Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
(
- Contribution to journal › Article
- 2002
-
Mark
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
(
- Contribution to journal › Article
-
Mark
The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats.
(
- Contribution to journal › Article
- 2001
-
Mark
Effects of inhibition of PAF, ICAM-1, and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
(
- Contribution to journal › Article